Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Lewin

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
BJU International|March 31, 2022
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centresElizabeth A Connolly, Andrew Weickhardt, Peter Grimison, et al.
Nature Medicine|May 6, 2016
Facilitating a culture of responsible and effective sharing of cancer genome dataLillian L Siu, Mark Lawler, David Haussler, et al.
Internal Medicine Journal|December 17, 2019
The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patientsDaniel Lapirow, Andre La Gerche, Claudia Toro, et al.
Pediatric Blood & Cancer|May 8, 2024
The Australian New Zealand Consortium in Children, Adolescents, and Young Adults Oncofertility action planLei Shong Lau, Catherine Allingham, Antoinette Anazodo, et al.
Journal for Immunotherapy of Cancer|March 15, 2019
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)Derek L Clouthier, Scott C Lien, S Y Cindy Yang, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
BJU International|March 31, 2022
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centresElizabeth A Connolly, Andrew Weickhardt, Peter Grimison, et al.
Nature Medicine|May 6, 2016
Facilitating a culture of responsible and effective sharing of cancer genome dataLillian L Siu, Mark Lawler, David Haussler, et al.
Internal Medicine Journal|December 17, 2019
The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patientsDaniel Lapirow, Andre La Gerche, Claudia Toro, et al.
Pediatric Blood & Cancer|May 8, 2024
The Australian New Zealand Consortium in Children, Adolescents, and Young Adults Oncofertility action planLei Shong Lau, Catherine Allingham, Antoinette Anazodo, et al.
Journal for Immunotherapy of Cancer|March 15, 2019
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)Derek L Clouthier, Scott C Lien, S Y Cindy Yang, et al.
Pageof 8